Time to change the way we think about tuberculosis infection prevention and control in health facilities: insights from recent research

Abstract In clinical settings where airborne pathogens, such as Mycobacterium tuberculosis, are prevalent, they constitute an important threat to health workers and people accessing healthcare. We report key insights from a 3-year project conducted in primary healthcare clinics in South Africa, alongside other recent tuberculosis infection prevention and control (TB-IPC) research. We discuss the fragmentation of TB-IPC policies and budgets; the characteristics of individuals attending clinics with prevalent pulmonary tuberculosis; clinic congestion and patient flow; clinic design and natural ventilation; and the facility-level determinants of the implementation (or not) of TB-IPC interventions. We present modeling studies that describe the contribution of M. tuberculosis transmission in clinics to the community tuberculosis burden and economic evaluations showing that TB-IPC interventions are highly cost-effective. We argue for a set of changes to TB-IPC, including better coordination of policymaking, clinic decongestion, changes to clinic design and building regulations, and budgeting for enablers to sustain implementation of TB-IPC interventions. Additional research is needed to find the most effective means of improving the implementation of TB-IPC interventions; to develop approaches to screening for prevalent pulmonary tuberculosis that do not rely on symptoms; and to identify groups of patients that can be seen in clinic less frequently.

[1]  Richard G. White,et al.  Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods , 2023, BMJ Global Health.

[2]  F. Cobelens,et al.  Disease Transmission by Patients With Subclinical Tuberculosis , 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Dowdy,et al.  Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Deol,et al.  Direct estimates of absolute ventilation and estimated Mycobacterium tuberculosis transmission risk in clinics in South Africa , 2022, PLOS global public health.

[5]  A. Vassall,et al.  Estimating waiting times, patient flow, and waiting room occupancy density as part of tuberculosis infection prevention and control research in South African primary health care clinics , 2022, PLOS global public health.

[6]  T. Greenhalgh,et al.  Health worker experiences of implementing TB infection prevention and control: A qualitative evidence synthesis to inform implementation recommendations , 2022, PLOS global public health.

[7]  Richard G. White,et al.  Estimating the contribution of subclinical tuberculosis disease to transmission: An individual patient data analysis from prevalence surveys , 2022, medRxiv.

[8]  James Campbell,et al.  Urgent need to invest in health and care workers , 2022, The Lancet.

[9]  J. Oeltmann,et al.  Tuberculosis attributed to transmission within healthcare facilities, Botswana—The Kopanyo Study , 2022, Infection Control & Hospital Epidemiology.

[10]  N. Ford,et al.  Evaluation of HIV treatment outcomes with reduced frequency of clinical encounters and antiretroviral treatment refills: A systematic review and meta-analysis , 2022, PLoS medicine.

[11]  F. Cobelens,et al.  How “Subclinical” is Subclinical Tuberculosis? An Analysis of National Prevalence Survey Data from Zambia , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  A. Vassall,et al.  Using system dynamics modelling to estimate the costs of relaxing health system constraints: a case study of tuberculosis prevention and control interventions in South Africa , 2021, Health Policy and Planning.

[13]  T. Ndung’u,et al.  Prevalence of Mycobacterium tuberculosis in Sputum and Reported Symptoms Among Clinic Attendees Compared With a Community Survey in Rural South Africa , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  C. Ku,et al.  Durations of asymptomatic, symptomatic, and care-seeking phases of tuberculosis disease with a Bayesian analysis of prevalence survey and notification data , 2021, BMC Medicine.

[15]  C. Colvin,et al.  Organisational Culture and Mask-Wearing Practices for Tuberculosis Infection Prevention and Control among Health Care Workers in Primary Care Facilities in the Western Cape, South Africa: A Qualitative Study , 2021, International journal of environmental research and public health.

[16]  R. Chaisson,et al.  Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis , 2021, The Lancet. Infectious diseases.

[17]  C. Fraser,et al.  Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial , 2021, The lancet. HIV.

[18]  Richard G. White,et al.  Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa , 2021, BMJ Global Health.

[19]  Richard G. White,et al.  Modelling the effect of infection prevention and control measures on rate of Mycobacterium tuberculosis transmission to clinic attendees in primary health clinics in South Africa , 2021, BMJ Global Health.

[20]  R. White,et al.  Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens , 2021, PloS one.

[21]  A. Grant,et al.  Health system influences on the implementation of tuberculosis infection prevention and control at health facilities in low-income and middle-income countries: a scoping review , 2021, BMJ Global Health.

[22]  D. Dowdy,et al.  Infection status of contacts is not associated with severity of TB in the index case. , 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[23]  A. Chughtai,et al.  Context matters: Examining the factors impacting the implementation of tuberculosis infection prevention and control guidelines in health settings in seven high tuberculosis burden countries. , 2021, Journal of infection and public health.

[24]  B. Allegranzi,et al.  Implementation of the infection prevention and control core components at the national level: a global situational analysis , 2020, The Journal of hospital infection.

[25]  A. Grant,et al.  ‘It has become everybody’s business and nobody’s business’: Policy actor perspectives on the implementation of TB infection prevention and control (IPC) policies in South African public sector primary care health facilities , 2020, Global public health.

[26]  A. Grant,et al.  Barriers and facilitators of tuberculosis infection prevention and control in low- and middle-income countries from the perspective of healthcare workers: A systematic review , 2020, PloS one.

[27]  G. Gartlehner,et al.  [WHO Guidelines on Tuberculosis Infection Prevention and Control]. , 2020, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[28]  A. Odone,et al.  Subclinical Tuberculosis Disease—A Review and Analysis of Prevalence Surveys to Inform Definitions, Burden, Associations, and Screening Methodology , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  J. Seeley,et al.  Tuberculosis infection prevention and control: why we need a whole systems approach , 2020, Infectious Diseases of Poverty.

[30]  R. Wood,et al.  Aerosolization of Mycobacterium tuberculosis by Tidal Breathing , 2020, bioRxiv.

[31]  Nicholas Stacey,et al.  Estimating a cost-effectiveness threshold for health care decision-making in South Africa , 2020, Health policy and planning.

[32]  E. Nardell,et al.  Cool but dangerous: How climate change is increasing the risk of airborne infections. , 2020, Indoor air.

[33]  S. Birring,et al.  Exhaled Mycobacterium tuberculosis output and detection of subclinical disease by face-mask sampling: prospective observational studies , 2020, The Lancet. Infectious diseases.

[34]  B. Allegranzi,et al.  Creation of a national infection prevention and control programme in Sierra Leone, 2015 , 2019, BMJ Global Health.

[35]  D. Dowdy,et al.  Screening for tuberculosis: time to move beyond symptoms. , 2019, The Lancet. Respiratory medicine.

[36]  A. R. Escombe,et al.  Improving natural ventilation in hospital waiting and consulting rooms to reduce nosocomial tuberculosis transmission risk in a low resource setting , 2019, BMC Infectious Diseases.

[37]  A. Crampin,et al.  Risk of Mycobacterium tuberculosis transmission in an antiretroviral therapy clinic , 2018, AIDS.

[38]  V. Zweigenthal,et al.  Assessing the impact of a waiting time survey on reducing waiting times in urban primary care clinics in Cape Town, South Africa , 2017, Journal of public health in Africa.

[39]  F. Tanser,et al.  Measuring ventilation and modelling M. tuberculosis transmission in indoor congregate settings, rural KwaZulu-Natal , 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[40]  P. Sonnenberg,et al.  Bioaerosol production by patients with tuberculosis during normal tidal breathing: implications for transmission risk , 2016, Thorax.

[41]  Richard G. White,et al.  The transmission of Mycobacterium tuberculosis in high burden settings. , 2016, The Lancet. Infectious diseases.

[42]  M. Pagano,et al.  Institutional Tuberculosis Transmission. Controlled Trial of Upper Room Ultraviolet Air Disinfection: A Basis for New Dosing Guidelines. , 2015, American journal of respiratory and critical care medicine.

[43]  E. Nardell,et al.  F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[44]  T. Cohen,et al.  High Rates of Potentially Infectious Tuberculosis and Multidrug-Resistant Tuberculosis (MDR-TB) among Hospital Inpatients in KwaZulu Natal, South Africa Indicate Risk of Nosocomial Transmission , 2014, PloS one.

[45]  Leslie London,et al.  Wind-Driven Roof Turbines: A Novel Way to Improve Ventilation for TB Infection Control in Health Facilities , 2012, PloS one.

[46]  A. R. Escombe,et al.  Upper-Room Ultraviolet Light and Negative Air Ionization to Prevent Tuberculosis Transmission , 2009, PLoS medicine.

[47]  Richard L Vincent,et al.  Safety of Upper-Room Ultraviolet Germicidal Air Disinfection for Room Occupants: Results from the Tuberculosis Ultraviolet Shelter Study , 2008, Public health reports.

[48]  A. R. Escombe,et al.  Natural Ventilation for the Prevention of Airborne Contagion , 2007, PLoS medicine.

[49]  D. Milton,et al.  Risk of indoor airborne infection transmission estimated from carbon dioxide concentration. , 2003, Indoor air.

[50]  K. Schwartzman,et al.  Measuring ventilation of patient care areas in hospitals. Description of a new protocol. , 1995, American journal of respiratory and critical care medicine.

[51]  L. Moulton,et al.  A Cluster Randomized Trial of Systematic Targeted Universal Testing for Tuberculosis in Primary Care Clinics of South Africa (The TUTT Study) , 2022, SSRN Electronic Journal.

[52]  J. Seeley,et al.  Beyond checklists: Using clinic ethnography to assess the enabling environment for tuberculosis infection prevention control in South Africa. , 2022, PLOS Global Public Health.

[53]  OUP accepted manuscript , 2021, Clinical Infectious Diseases.

[54]  Environmental Control for Tuberculosis : Basic Upper-Room Ultraviolet Germicidal Irradiation Guidelines for Healthcare Settings , 2009 .